StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$10.88+0.01 (+0.05%)

Close on Nov 13, 2026Market cap $210.08MP/E –Yield –

Translational Development Acquisition ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Translational Development Acquisition

Translational Development Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Translational Development Acquisition figures

See a number that looks wrong?